Relevium Targets 30 New Bioganix® Gold Products in Walmart by Year End and Prepares to Launch in Canada
MONTREAL, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announced its plans to increase its presence in Walmart.com and ramp up its current offering to over thirty (30) SKUs before the end of the year.
Following the successful initial test launch of three (3) SKUs, the Company is now ready to introduce up to thirty (30) new SKUs of its Bioganix® Gold Series formulated products before the end of this year. The Company has also begun the regulatory and compliance process to launch its formulated products in the Canadian market and plans to test walmart.ca as soon as the products obtain natural health product approvals from Health Canada.
"Following an initial market testing period, we are now expanding our presence in walmart.com to over thirty (30) SKUs and we are targeting walmart.ca platform for the initial launch of the Bioganix® Gold Series brand into the Canadian market” stated Abis Hussain, Chief Marketing Officer.
“We are working through the regulatory process to launch two (2) exclusive science based formulated products into the Canadian market and we are monitoring Walmart’s recently announced intention to explore the cannabis infused market as we see this as a potential platform for our LeefyLyfe® brand for North America” stated Aurelio Useche, Chief Executive Officer
The Company continues to make significant progress in its OTC nutraceutical formulated business and recently announced a line of hemp derived organic CBD infused products under the LeefyLyfe® brand for the European market.
About Relevium Technologies
Relevium is a publicly-traded company that operates in the health and wellness industry, a multi-billion-dollar market worldwide.
Relevium markets its products as dietary supplements, nutraceuticals, sports nutrition and nutri-cosmeceuticals. The Company plans on unveiling a complete line of dietary supplements for consumers derived from Cannabis Sativa and Cannabis Indica. The Company’s initial focus will be on creating a full spectrum extract rich in CBD (cannabidiol) which will be marketed and sold throughout North America. Relevium is also focused on developing a complete line of supplements, nutraceuticals, sports nutrition and nutri-cosmeceuticals. Relevium’s products and brands such as Bioganix® have achieved market penetration and now sold at some of the world’s largest retailers such as Walmart.com.
Relevium is also focused on the development, acquisition, marketing and sale of consumer products that are derived from cannabis and industrial hemp and other ingredients that are generally accepted as safe. The Company uses cannabinoids and ingredients that have achieved GRAS status (generally accepted as safe) to create brands that are sold via wholesale channels, retail channels and online distribution.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.